Automated emails and letters that provide personalized feedback related to cafeteria purchases at work may help employees make healthier food choices.
Explore This Research Lab
The main focus of my research is to investigate and understand the pathophysiology of dysfunctional hemodialysis access. We use novel in vivo molecular imaging approaches to image and predict the stenosis and failure in arteriovenous fistulas using animal models. Our goal is to translate these technologies to patients with dysfunctional dialysis access to detect stenosis earlier and eventually prevent the development of stenosis. Our clinical research is focused on improving outcomes of access interventions using novel techniques.
- Cui J, Kessinger CW, McCarthy JR, Sosnovik DE, Libby P, Thadhani RI, Jaffer FA. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula. Arterioscler Thromb Vasc Biol. 2015; 35(1): 189-96.
- Cui J, Kawai T, Irani Catheter-directed Thrombolysis in Acute Superior Vena Cava Syndrome Caused by Central Venous Catheters. Semin Dial. 2015; 28(5): 548-51.
- Cui J, Freed R, Liu F, Irani Interrupting Rivaling Access-flow with Nonsurgical Image-guided ligation: the "IRANI" Procedure. Semin Dial. 2015; 28(6): E53-7.
- Cui J, Steele D, Wenger J, Kawai T, Liu F, Elias N, Watkins MT, Irani Z. Hemodialysis arteriovenous fistula as first option not necessary in elderly patients. J Vasc Surg. 2016 Jan 6
- Department of Medicine
- Staff Story
- Nov | 17 | 2020
Winfred W. Williams, MD, has been named a deputy editor of The New England Journal of Medicine. Williams, who is associate chief of the Division of Nephrology, becomes the first African American to serve in that role.
- Press Release
- Sep | 2 | 2020
Mass General study demonstrates that kidneys infected with hepatitis C can be safely transplanted into healthy recipients
Mass General study demonstrates that kidneys infected with hepatitis C can be safely transplanted into healthy recipients.
- Jul | 22 | 2020
In this roundup, scientists and researchers at Massachusetts General Hospital answer your most frequently asked questions on COVID-19, vaccines, clinical trials and testing.
- Jun | 23 | 2020
Given the worldwide demand for vaccines to stop the spread of COVID-19, experts believe it will be important to move as many promising candidates forward as possible.
- Press Release
- Jun | 9 | 2020
A drug already in use for several cancers was found effective in a study of leptomeningeal dissemination of cancer.
About the Nephrology Division
The Division of Nephrology at Massachusetts General Hospital is a leading provider of services for patients with kidney disease, including diagnosis and management of kidney diseases and medical management of renal transplantation.